MAGNETIC-VT: A prospective, multi-center, post market randomized controlled trial comparing VT ablation outcomes using remote MAGNETIC navigation guided substrate mapping and ablation versus manual approach in a low LVEF population

IRB Protocol#: 1612017824

ClinicalTrials.gov Identifier: NCT02637947

Overview: The purpose of this study is to compare two kinds of systems that are used to control the catheter during VT ablation: one that uses magnetic fields and one that uses a manual pull wire. Both kinds of systems are approved by the Food and Drug Administration (FDA), and both are regularly used by the cardiologists at WCMC/NYPH. The study is being done because it is not known whether one kind of system provides better results than the other.

This trial is funded by Stereotaxis.

To be eligible, patients must:

• Be a candidate for VT ablation
• Have failed at least one drug therapy in managing VT
• Have an ICD previously implanted
• Have had a myocardial infarction
• Have a left ventricular ejection fraction (LVEF) less than or equal to 35%

Patients cannot participate if they have:

• A history of stroke within 1 month prior to enrollment
• Had an acute myocardial infarction within 30 days prior to enrollment
• Undergone cardiac surgery within 60 days prior to enrollment
• Had a previous pericarditis or cardiac tumor

Contact:

Dr. Jim Cheung
Principle Investigator
Email: Jac9029@med.cornell.edu
Phone: (212) 746-2158

Grace Lee
Research Coordinator
Email: Grl2008@med.cornell.edu
Phone: (646) 962-8493